RedHill's RHB-102 (BEKINDA®) and Opaganib Granted New Patents in Oncology Setting

Provided By PR Newswire

Last update: May 1, 2023

European Patent Office grants RHB-102 patent covering antiemetic extended-release solid dosage forms for the prevention of nausea and vomiting (CINV/RINV), providing protection of RHB-102 to March 2034